DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $24.00 by Analysts at Robert W. Baird

DENTSPLY SIRONA (NASDAQ:XRAY) had its target price cut by investment analysts at Robert W. Baird from $31.00 to $24.00 in a research note issued to investors on Friday,Benzinga reports. The firm presently has a “neutral” rating on the medical instruments supplier’s stock. Robert W. Baird’s target price indicates a potential upside of 39.05% from the company’s current price.

A number of other equities analysts have also recently issued reports on the company. Barrington Research reaffirmed an “outperform” rating and issued a $36.00 target price on shares of DENTSPLY SIRONA in a report on Friday, September 20th. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Wednesday. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday. Needham & Company LLC decreased their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Finally, Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Five equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $31.00.

DENTSPLY SIRONA Stock Down 28.0 %

Shares of NASDAQ XRAY opened at $17.26 on Friday. The company has a market cap of $3.50 billion, a price-to-earnings ratio of -20.07, a PEG ratio of 1.31 and a beta of 1.02. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. DENTSPLY SIRONA has a 12 month low of $17.22 and a 12 month high of $37.60. The stock has a 50-day moving average price of $24.82 and a two-hundred day moving average price of $25.98.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several hedge funds and other institutional investors have recently made changes to their positions in XRAY. Raymond James Trust N.A. increased its stake in DENTSPLY SIRONA by 4.9% in the 2nd quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after buying an additional 453 shares during the last quarter. State of Alaska Department of Revenue lifted its holdings in DENTSPLY SIRONA by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after acquiring an additional 560 shares during the period. LRI Investments LLC boosted its position in DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after purchasing an additional 564 shares during the last quarter. Diversified Trust Co grew its stake in DENTSPLY SIRONA by 3.0% in the 2nd quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock valued at $489,000 after purchasing an additional 566 shares during the period. Finally, Allworth Financial LP increased its position in shares of DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after purchasing an additional 625 shares during the last quarter. 95.70% of the stock is owned by institutional investors.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.